Company news

Acumen Pharmaceuticals, Inc. news in 2021

Acumen Pharmaceuticals, Inc.'s news releases, calls and decks from 2021, newest first.

View company

Acumen Pharmaceuticals Reports Financial Results for Third Quarter 2021 and Business Highlights

November 14, 2021

Acumen Announces First Patient Dosed in a Phase 1 Clinical Trial of ACU193, a Monoclonal Antibody that Selectively Targets Toxic Aβ Oligomers for the Treatment of Early Alzheimer’s Disease

October 6, 2021

Acumen Pharmaceuticals Announces Pricing of Upsized Initial Public Offering

June 29, 2021

Decks in 2021